| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 4 |
| 1 | LOSARTAN | 4 |
| 2 | AMLODIPINE | 3 |
| 3 | POTASSIUM CHLORIDE | 3 |
| 4 | POTASSIUM CHLORIDE EXTENDED-RELEASE | 3 |
| 5 | POTASSIUM CHLORIDE ORAL | 3 |
| 6 | POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE | 3 |
| 7 | ALLOPURINOL | 1 |
| 8 | AMINOLEVULINIC ACID HYDROCHLORIDE | 1 |
| 9 | APIXABAN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMINOLEVULINIC ACID HYDROCHLORIDE | 1 | 0.0006 |
| 1 | INSULIN DEGLUDEC | 1 | 0.0000 |
| 2 | AZACITIDINE | 1 | 0.0000 |
| 3 | POTASSIUM CHLORIDE ORAL | 3 | 0.0000 |
| 4 | POTASSIUM CHLORIDE | 3 | 0.0000 |
| 5 | LOSARTAN | 4 | 0.0000 |
| 6 | APIXABAN | 1 | 0.0000 |
| 7 | DIGOXIN | 1 | 0.0000 |
| 8 | LOSARTAN POTASSIUM | 1 | 0.0000 |
| 9 | DULAGLUTIDE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 4 |
| 1 | Calcium Channel Blocker [EPC] | 3 |
| 2 | Dihydropyridine Calcium Channel Blocker [EPC] | 3 |
| 3 | Osmotic Laxative [EPC] | 3 |
| 4 | Potassium Salt [EPC] | 3 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 6 | Cardiac Glycoside [EPC] | 1 |
| 7 | Factor Xa Inhibitor [EPC] | 1 |
| 8 | GLP-1 Receptor Agonist [EPC] | 1 |
| 9 | Insulin Analog [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 1 | Osmotic Laxative [EPC] | 3 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 3 | Dihydropyridine Calcium Channel Blocker [EPC] | 3 | 0.0000 |
| 4 | Loop Diuretic [EPC] | 4 | 0.0000 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 1 | 0.0000 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |